Back to Search Start Over

Re-routing of Sugar Catabolism Provides a Better Insight Into Fungal Flexibility in Using Plant Biomass-Derived Monomers as Substrates.

Authors :
Chroumpi T
Peng M
Markillie LM
Mitchell HD
Nicora CD
Hutchinson CM
Paurus V
Tolic N
Clendinen CS
Orr G
Baker SE
Mäkelä MR
de Vries RP
Source :
Frontiers in bioengineering and biotechnology [Front Bioeng Biotechnol] 2021 Mar 08; Vol. 9, pp. 644216. Date of Electronic Publication: 2021 Mar 08 (Print Publication: 2021).
Publication Year :
2021

Abstract

The filamentous ascomycete Aspergillus niger has received increasing interest as a cell factory, being able to efficiently degrade plant cell wall polysaccharides as well as having an extensive metabolism to convert the released monosaccharides into value added compounds. The pentoses D-xylose and L-arabinose are the most abundant monosaccharides in plant biomass after the hexose D-glucose, being major constituents of xylan, pectin and xyloglucan. In this study, the influence of selected pentose catabolic pathway (PCP) deletion strains on growth on plant biomass and re-routing of sugar catabolism was addressed to gain a better understanding of the flexibility of this fungus in using plant biomass-derived monomers. The transcriptome, metabolome and proteome response of three PCP mutant strains, Δ larA Δ xyrA Δ xyrB , Δ ladA Δ xdhA Δ sdhA and Δ xkiA , grown on wheat bran (WB) and sugar beet pulp (SBP), was evaluated. Our results showed that despite the absolute impact of these PCP mutations on pure pentose sugars, they are not as critical for growth of A. niger on more complex biomass substrates, such as WB and SBP. However, significant phenotypic variation was observed between the two biomass substrates, but also between the different PCP mutants. This shows that the high sugar heterogeneity of these substrates in combination with the high complexity and adaptability of the fungal sugar metabolism allow for activation of alternative strategies to support growth.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2021 Chroumpi, Peng, Markillie, Mitchell, Nicora, Hutchinson, Paurus, Tolic, Clendinen, Orr, Baker, Mäkelä and de Vries.)

Details

Language :
English
ISSN :
2296-4185
Volume :
9
Database :
MEDLINE
Journal :
Frontiers in bioengineering and biotechnology
Publication Type :
Academic Journal
Accession number :
33763411
Full Text :
https://doi.org/10.3389/fbioe.2021.644216